Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

NCPDP, the standards development organization focused on the pharmacy sector, just wrapped up its annual business and technology conference, which immediately followed its quarterly technical ...

View Blog Post
Blog Post

Opioid analgesics remain the first-line treatment for moderate-to-severe acute pain in emergency departments. But a study published in JAMA 2017 showed tha...

View Blog Post
Blog Post

While studies confirm that prescription drug monitoring programs (PDMPs) do help states reduce misuse and diversion of opioid drug products, many professionals and research data still report variable benefits, inconsistent usag...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up